Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
BBTX · NASDAQ · Biological Products, (No Diagnostic Substances) · No 10-K yet
Bambusa Therapeutics (BBTX) · oqro.io/stocks/BBTX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$16.09
Close of Nov 13, 2026 · end-of-day, not a live quote
24 routine filings (option exercises, shares withheld for taxes, grants, gifts) are not listed here. Show them
Traded Oct 30 – Nov 2, 2026 · largest single transaction ~$37.4M
Nov 2, 2026~$37.4M · 2.34M sh @ $16.00
DetailsOfficial recordOct 30, 2026~$3.94M · 264K sh @ $14.92
DetailsOfficial recordOct 30, 2026~$2.7M · 190K sh @ $14.23
DetailsOfficial recordInsider buying
Traded Nov 2 · filed the same day
Since the trade +0.6% · S&P 500 +0.3% · to Nov 13
A major shareholder of Bambusa Therapeutics paid $6M out of pocket for Bambusa Therapeutics shares. 2 other people at Bambusa Therapeutics bought some too, in the same month.
Insider buying
Traded Nov 2 · filed the same day
Since the trade +0.6% · S&P 500 +0.3% · to Nov 13
A Bambusa Therapeutics director paid $6M out of pocket for Bambusa Therapeutics shares. 2 other people at Bambusa Therapeutics bought some too, in the same month.
Nov 2, 2026~$2.64M · 165K sh @ $16.00
DetailsOfficial recordNo earnings release (8-K Item 2.02) is on file for BBTX, so its insider trades cannot be placed against one.